SCHEMBL3300844

SCHEMBL3300844

Fc1cc(Cl)cc(C(F)(F)F)c1Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 2/20 0.39
HSD11B1 P28845 2/20 0.37
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
NOTUM Q6P988 1/20 0.33
ALDH1A1 P00352 1/20 0.32
VEGFA P15692 1/20 0.32
TSHR P16473 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
GPR3 P46089 1/20 0.32
KIF11 P52732 2/20 0.31
AHR P35869 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
PDK2 Q15119 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11600376 0.85 EPAS1 (0.40) EPAS1HSD11B1HTR2AHTR2CCYP1A2
SCHEMBL27796545 0.78 ALDH1A1 (0.52) EPAS1HSD11B1CYP1A2CYP2D6CYP2C19
SCHEMBL31619143 0.77 EPAS1 (0.37) EPAS1NOTUMCYP11B1CYP11B2GPR3
SCHEMBL24602620 0.76 TSHR (0.47) CYP1A2CYP2C19ALDH1A1TSHRAHR
SCHEMBL13550065 0.74 RAPGEF4 (0.40) EPAS1HSD11B1CYP1A2CYP2D6CYP2C19
SCHEMBL10776564 0.74 CYP3A4 (0.41) EPAS1CYP1A2CYP2D6CYP2C19RAB9A
SCHEMBL31611799 0.74 KIF11 (0.47) ALDH1A1KIF11
SCHEMBL31303886 0.73 SLC6A4 (0.46) HSD11B1HTR2ACYP1A2CYP2D6CYP2C19
SCHEMBL657298 0.73 SLC6A4 (0.46) HSD11B1HTR2ACYP1A2CYP2D6CYP2C19
SCHEMBL7271102 0.73 KIF11 (0.39) EPAS1HSD11B1HTR2AHTR2CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096585-A1 Process for Preparing 2,6-Dichloro-4-(Trifluoromethyl)Phenylhydrazine Using Mixtures of Dichloro-Fluoro-Trifluoromethylbenzenes BASF SE (DE) 2010-04-22 US claimed
EP-2137135-A1 PROCESS FOR PREPARING 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYLHYDRAZINE USING MIXTURES OF DICHLORO-FLUORO-TRIFLUOROMETHYLBENZENES BASF SE (DE) 2009-12-30 EP claimed
WO-2008113660-A1 PROCESS FOR PREPARING 2,6-DICHLORO-4-(TRIFLUOROMETHYL)PHENYLHYDRAZINE USING MIXTURES OF DICHLORO-FLUORO-TRIFLUOROMETHYLBENZENES BASF SE (DE) 2008-09-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096585-A1 Process for Preparing 2,6-Dichloro-4-(Trifluoromethyl)Phenylhydrazine Using Mixtures of Dichloro-Fluoro-Trifluoromethylbenzenes DAZAP1, CYP4Z1, CYP2F1 EPAS1 3144/4885HSD11B1 813/4885HTR2A 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.